866-997-4948(US-Canada Toll Free)

Game Changers Cancer Immunotherapies: Checkpoint Inhibitors

Published By :

IData Insight

Published Date : Sep 2015

Category :

Cancer

No. of Pages : N/A


Report Highlights:
  • How checkpoint inhibitors are revolutionizing treatment options and expectations for cancer patients
  • An overview of global melanoma market
  • Case studies on Opdivo, Keytruda and Yervoy
  • Market potential of Opdivo and Keytruda
A must buy for:

Professional from the pharmaceutical, biotech, medical device and diagnostics industries with responsibilities or involvement in the following areas:
  • Competitive Intelligence
  • Business Intelligence
  • Information Specialist
  • Commercial/Customer Insights
  • Strategic Planning
  • Market/Marketing Research
  • Decision Analysis/Decision Support
  • Business Analytics
  • New Product Planning/Development
  • Forecasting
  • Librarian
  • Brand Management/Product Management
  • Marketing
  • Business Portfolio Planning
  • Strategic/Business Analysis
  • Business Development
  • Licensing
  • Techni cal Anal ysi s
  • Portfolio Management/Planning
  • Project Management
  • Risk Management
  • Research Planning
  • Research & Development
  • Regulatory
  • Scientist
  • Legal/Regulatory
  • Outsourcing
  • Manufacturing

1. Executive Summary

2. Introduction
PD-1/PD-L1 Pathway
Role of PD-1/PD-L1 Pathway
Drugs Targeting the PD-1 vs. PD-L1 Pathway
Patterns and Evaluation of Response
Safety
PD-L1 Inhibitors
PD-1 Inhibitors
Rationale for Combination Therapies
PD-L1 as a Predictive Biomarker
Cytotoxic T-Lymphocyte Associated Antigen (CTLA-4) Pathway

3. Case Study 1: Opdivo (Bristol-Myers Squibb)
Product Profile
Development Timeline
Clinical Trial Profiles
Pricing Scenario
Regulatory Scenario
Life Cycle Management Activities

4. Case Study 2: Keytruda (Merck)
Product Profile
Development Timeline
Clinical Trial Profiles
Pricing Scenario
Regulatory Scenario
Life Cycle Management Activities

5. Case Study 3: Yervoy (Bristol-Myers Squibb)
Product Profile
Development Timeline
Clinical Trial Profiles
Pricing Scenario
Regulatory Scenario
Life Cycle Management Activities

6. Efficacy and Safety Comparison on Opdivo, Keytruda and Yervoy in Melanoma

7. Global Melanoma Market Overview

8. The PD-1 Wave: Opdivo and Keytruda Market Potential

9. KOL Comments: Analysis of Statements from Various KOLs

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *